Naomi Waithira Selected Research

artenimol (dihydroartemisinin)

1/2020	Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
1/2019	Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults.
1/2019	Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naomi Waithira Research Topics

Disease

9	Malaria 10/2023 - 01/2019
6	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2023 - 01/2019
4	Infections 03/2024 - 01/2022
4	Glucosephosphate Dehydrogenase Deficiency 10/2023 - 01/2023
4	Vomiting 01/2023 - 01/2020
3	COVID-19 01/2023 - 01/2020
2	Fever (Fevers) 07/2023 - 01/2019
2	Nausea 01/2023 - 01/2022
2	Abdominal Pain (Pain, Abdominal) 01/2023 - 10/2021
2	Vivax Malaria 01/2023 - 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2024
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Anorexia 01/2023
1	Melioidosis 01/2023
1	Zoonoses 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Scrub Typhus (Typhus, Scrub) 01/2023
1	Bradycardia 01/2022
1	Headache (Headaches) 10/2021
1	Hypersensitivity (Allergy) 10/2021
1	Neoplasms (Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

6	artemisinin (artemisinine)IBA 01/2022 - 01/2019
5	Primaquine FDA Link 10/2023 - 01/2019
5	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2023 - 01/2020
4	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2023 - 01/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2019
4	Mefloquine (Lariam)FDA LinkGeneric 10/2021 - 01/2019
4	piperaquineIBA 10/2021 - 01/2019
3	Antimalarials (Antimalarial Agents)IBA 01/2023 - 01/2019
3	artenimol (dihydroartemisinin)IBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2023
2	Amodiaquine (Camoquin)FDA Link 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2020
1	Sickle HemoglobinIBA 10/2023
1	BilirubinIBA 10/2023
1	Hemoglobins (Hemoglobin)IBA 10/2023
1	Doxycycline (Periostat)FDA LinkGeneric 01/2023
1	MCOIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Bacterial DNAIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	arterolaneIBA 10/2021
1	ArtemisininsIBA 01/2019

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2019
2	Chemoprevention 01/2023 - 01/2021
1	Self Medication 07/2023
1	Retreatment 01/2022
1	Contraindications 10/2021